Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
ClarVista Medical
AddedFeb 15, 2024
UpdatedJun 18, 2026
ClarVista Medical

ClarVista Medical

Series B

ClarVista Medical develops innovative ophthalmic products, focusing on treating challenging eye conditions.

HQ
Aliso Viejo, CA, US
Founded
2012
Overview
Compare
Fundraising
Employees

ClarVista Medical develops innovative ophthalmic products, focusing on treating challenging eye conditions. Founded in 2012 as a spin-out from Prospex Medical, the company aims to advance the field of ophthalmology with its flagship product, the HARMONI™ IOL system. This intraocular lens system is designed to improve outcomes for patients undergoing cataract surgery.

ClarVista Medical has achieved significant milestones, including the development of the first-generation HARMONI™ system and conducting successful first-in-human clinical studies. The company has also built a robust intellectual property portfolio, positioning itself as a leader in ophthalmic innovation.

ClarVista Medical - Similar Companies

Clearsight logo

Clearsight

Claria Medical logo

Claria Medical

Neovista logo

Neovista

Atia Vision logo

Atia Vision

atiavision.com

RxSight logo

RxSight

rxsight.com

Clarimedix logo

Clarimedix

Elenza logo

Elenza

elenza.com

Opticent Health logo

Opticent Health

opticenthealth.com

Clarix Imaging logo

Clarix Imaging

clariximaging.com

Clerio Vision logo

Clerio Vision

cleriovision.com

Prospex Medical logo

Prospex Medical

ClearSpec logo

ClearSpec

Endovista logo

Endovista

endovistainc.com

Forsight Vision6 logo

Forsight Vision6

ClearCam logo

ClearCam

clearcam-med.com

ClarVista Medical - Quick Facts

Who are ClarVista Medical's competitors?

Companies similar to ClarVista Medical include Clearsight, Claria Medical, Neovista and Atia Vision.

When was ClarVista Medical founded?

ClarVista Medical was founded in 2012.

Where is ClarVista Medical's headquarters located?

ClarVista Medical's headquarters is located in Aliso Viejo, CA, US.

When was ClarVista Medical's last funding round?

ClarVista Medical's most recent funding round was for $14.5M (USD) in May 2015.

How much has ClarVista Medical raised to-date?

As of May 20, 2015, ClarVista Medical has raised a total of $14.5M (USD).

How many employees does ClarVista Medical have?

ClarVista Medical has 30 employees as of Feb 5, 2024.

ClarVista Medical - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
  • HealthTech
Geographic Exposure
  • Americas
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Hardware
  • Software
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 9 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 330000Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies